pembrolizumab April 17, 2017 pembrolizumab Trade Name Ketruda Orphan Indication Primary mediastinal B cell lymphoma USA Market Approval USA USA Designation Date 2016-01-14 00:00:00 Sponsor Merck, Sharp & Dohme Corp.;One Merck Drive;Whitehouse Station, New Jersey, 08889
